138 related articles for article (PubMed ID: 32723981)
1. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
Farzaneh T; Nowroozizadeh B; Han M; Lee W
Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
[TBL] [Abstract][Full Text] [Related]
4. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.
Dinarvand P; Wang WL; Roy-Chowdhuri S
Cytopathology; 2022 Mar; 33(2):216-221. PubMed ID: 34816516
[TBL] [Abstract][Full Text] [Related]
5. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
Guo W; Farzaneh T; Lee W; Nael A; Li X; Chandan VS
Pathol Res Pract; 2021 Jul; 223():153462. PubMed ID: 34048981
[TBL] [Abstract][Full Text] [Related]
6. Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors.
Zhao P; deBrito P; Ozdemirli M; Sidawy MK
Diagn Cytopathol; 2013 Oct; 41(10):889-95. PubMed ID: 23584981
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
8. Utility of cytomorphology in distinguishing solid pseudopapillary neoplasm of pancreas from pancreatic neuroendocrine tumor with emphasis on nuclear folds and nuclear grooves.
Misra S; Saran RK; Srivastava S; Barman S; Dahale A
Diagn Cytopathol; 2019 Jun; 47(6):531-540. PubMed ID: 30677247
[TBL] [Abstract][Full Text] [Related]
9. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
10. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
Schmitt AC; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
[TBL] [Abstract][Full Text] [Related]
11. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network.
Li P; Hu Y; Yi J; Li J; Yang J; Wang J
J Transl Med; 2015 Nov; 13():361. PubMed ID: 26578390
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
Foo WC; Harrison G; Zhang X
Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
15. LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
Kim EK; Jang M; Park M; Kim H
Oncotarget; 2017 Nov; 8(55):93404-93413. PubMed ID: 29212159
[TBL] [Abstract][Full Text] [Related]
16. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
Haynes CM; Sangoi AR; Pai RK
Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
[TBL] [Abstract][Full Text] [Related]
17. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
18. EUS-guided FNA cytology of pancreatic neuroendocrine tumour (PanNET): a retrospective study of 132 cases over an 18-year period in a single institution.
Chen S; Lin J; Wang X; Wu HH; Cramer H
Cytopathology; 2014 Dec; 25(6):396-403. PubMed ID: 24635775
[TBL] [Abstract][Full Text] [Related]
19. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration.
Ahmed A; VandenBussche CJ; Ali SZ; Olson MT
Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138
[TBL] [Abstract][Full Text] [Related]
20. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.
Meriden Z; Shi C; Edil BH; Ellison T; Wolfgang CL; Cornish TC; Schulick RD; Hruban RH
Am J Surg Pathol; 2011 Jul; 35(7):981-8. PubMed ID: 21677537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
